Stanford Meningioma Program

The Stanford Meningioma Program combines a multidisciplinary clinical care team with a strong clinical and research program, in an effort to facilitate the rapid transfer of basic scientific findings into clinical protocols for patients with tumors of the brain, including meningiomas. Meningiomas are the most common type of brain tumor, are typically benign, and may remain for years before they're identified by a doctor. While they often do not cause problems, some meningiomas do require treatment. At our Center, our team of doctors and specialists create an individulized treatment plan, which may include active surveillance, minimally invasive surgery such as endoscopic endonasal surgery, radiation therapy, or a combination of surgery and radiation therapy.  


Types of Meningiomas

  • There are several types of meningiomas. The tumors are classified based on where they form in the brain:
  • Convexity meningiomas grow on the brain's surface. Tumors may not trigger symptoms until they become large enough to press on the brain.
  • Falcine and parasgittal meningiomas form in or near the very thin layer of tissue between the two sides (hemispheres) of the brain.
  • Intraventricular meningiomas form in the part of the brain that produces and distributes spinal fluid.
  • Skull-base meningiomas form in the bones in the bottom of the skull or in the boney ridge behind the eyes.
  • Sphenoid wing meningiomas form in the skull base behind the eyes.
  • Olfactory groove meningiomas form along the nerves that run between the brain and the nose. They can cause loss of smell and grow large enough to affect vision.
  • Posterior fossa/petrous meningiomas form on the underside of the brain and pressure the trigeminal nerve, triggering a condition called trigeminal neuralgia.
  • Suprasellar meningiomas originate in the base of the skull near the pituitary gland and optic nerve. They commonly trigger vision and pituitary problems.
  • Recurrent meningiomas are any meningiomas that return after treatment. They may share the same characteristics as the initial meningioma or may act more aggressively


Meet Our Team

Our multi-disciplinary team is comprised of some of the world's foremost experts in the treatment of meningiomas; including neurosurgeons, radiation and neuro oncologists, neuro radiologists, and neuro interventional radiologist. 

Endoscopic Endonasal Surgery

The surgical endoscopic endonasal approach (EEA) for treating meningiomas uses minimally invasive techniques for early tumor devascularization, direct access to the tumor's origin, and minimizes complications. 


The Department of Neurosurgery is a world leader in the fast-paced environment of innovative research translation. The rich intellectual environment at Stanford, paired with our accessibility to the most advanced technology, is unmatched and ensures the rapid translation of pioneering laboratory research into life-saving clinical therapies for our patients.

Clinical Trials

We currently have multiple clinical trials  at Stanford evaluating new medical approaches, devices, drugs, or other treatments for meningiomas that are recruiting participants. 

Stanford Brain Tumor Center

Successful treatment of brain tumors leads to a longer, better quality of life. At the Stanford Brain Tumor Center, our doctors are at the forefront of the latest, successful brain tumor diagnosis, treatment and clinical trials options.

Affiliated Programs

Our Center has innovative clinical initiatives organized in partnership with the following Stanford programs:


CyberKnife was invented at Stanford and treats a variety of conditions, including meningiomas, with high-dose radiation therapy. The Cyberknife's special quality is that it tracks tumor movement whether from breathing or other patient motion. Its beam delivery arm reacts with minute precision to real-time images of the tumor. No radiation is sent out when the tumor moves out of the beam, protecting healthy tissue. 

Video: New Technology Can Make Brain Surgery Safer